Objectives: To investigate the time course and the relation to prognos
is of coagulation and fibrinolytic abnormalities in patients with sept
ic shock. Patients and Methods: Forty-eight consecutive patients admit
ted to the medical ICU with the diagnosis of septic shock (diagnosed b
y defined criteria) were studied. Mortality was 25 of 48. Mean age was
57 +/- 7.3 years. Blood samples were obtained on days 1, 4, and 7 aft
er hospital admission to measure tissue-type plasminogen activator ant
igen (t-PA), urokinase-type plasminogen activator (u-PA), plasminogen
activator inhibitor antigen (PAI-1), plasminogen, alpha2-antiplasmin,
fibrinogen, antithrombin III, protein C, protein S, thrombin-antithrom
bin complexes (TAT), D-dimer, and von Willebrand factor-related antige
n (vWF:Ag). Results: All patients showed marked abnormalities in both
the coagulation and fibrinolytic systems. There were signs of coagulat
ion activation and elevation of both activators and inhibitors of fibr
inolysis. Nonsurvivors showed lower levels of protein C and antithromb
in III and higher concentration of TAT than survivors. While both t-PA
and PAI-1 concentrations were high in survivors and nonsurvivors, onl
y survivors showed a progressive normalization of both parameters duri
ng the study period. Low plasminogen levels and plasminogen/alpha2-ant
iplasmin ratio were found in both groups, presenting a trend toward no
rmalization only in survivors. The differences reported were not appar
ent at the time of hospital admission. Conclusions: Septic shock is ch
aracterized by coagulation activation and fibrinolysis activation and
inhibition. Nonsurvivors present a particular hemostatic profile chara
cterized by a more marked activation of coagulation and a more intense
inhibition of fibrinolysis. None of the abnormalities studied was sig
nificantly different between survivors and nonsurvivors at the time of
hospital admission. In the presence of fibrin formation, nonsurvivors
present a maintained imbalance in the fibrinolytic response determine
d by higher PAI-1 plasma concentration, probably contributing to their
poor outcome.